About Us
About Us
Regulatory Disclosures

Regulatory Disclosures – Banking (Disclosure) Rules

The following disclosures are made pursuant to the Banking (Disclosure) Rules : 

 

2024 Q2

Regulatory Disclosure Statement for the Position Date of 30 June 2024

 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2024 Q1

Regulatory Disclosure Statement for the Position Date of 31 March 2024

 
2023 Q4

Regulatory Disclosure Statement for the Position Date of 31 December 2023

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Key Elements of Disclosure Policy

2023 Q3

Regulatory Disclosure Statement for the Position Date of 30 September 2023

2023 Q2

Regulatory Disclosure Statement for the Position Date of 30 June 2023

 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2023 Q1

Regulatory Disclosure Statement for the Position Date of 31 March 2023

 
2022 Q4

Regulatory Disclosure Statement for the Position Date of 31 December 2022

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Key Elements of Disclosure Policy

2022 Q3

Regulatory Disclosure Statement for the Position Date of 30 September 2022

2022 Q2

Regulatory Disclosure Statement for the Position Date of 30 June 2022

 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2022 Q1

Regulatory Disclosure Statement for the Position Date of 31 March 2022

 
2021 Q4

Regulatory Disclosure Statement for the Position Date of 31 December 2021

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Key Elements of Disclosure Policy

2021 Q3

Regulatory Disclosure Statement for the Position Date of 30 September 2021

2021 Q2

Regulatory Disclosure Statement for the Position Date of 30 June 2021

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2021 Q1

Regulatory Disclosure Statement for the Position Date of 31 March 2021

 

2020 Q4 Regulatory Disclosure Statement for the Position Date of 31 December 2020
 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Key Elements of Disclosure Policy

2020 Q3

 

Regulatory Disclosure Statement for the Position Date of 30 September 2020

2020 Q2

 

Regulatory Disclosure Statement for the Position Date of 30 June 2020

 

 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2020 Q1

 

Regulatory Disclosure Statement for the Position Date of 31 March 2020

 

2019 Q4

 

Regulatory Disclosure Statement for the Position Date of 31 December 2019

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

 

Key Elements of Disclosure Policy

2019 Q3

Regulatory Disclosure Statement for the Position Date of 30 September 2019

2019 Q2

Regulatory Disclosure Statement for the Position Date of 30 June 2019

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2019 Q1

Quarterly Disclosures

 

2018 Q4

Annual Disclosures

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Key Elements of Disclosure Policy

2018 Q3

Quarterly Disclosures

2018 Q2

Semi-annual Disclosures

 

– 

Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2018 Q1

First Quarter Disclosures

 

2017 Q4

Annual Disclosures on Regulatory Capital

 

– 

Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Annual Disclosures on Leverage Ratio

 

Annual Disclosures on Pillar 3

 

Key Elements of Disclosure Policy

2017 Q3

Third Quarter Disclosures on Pillar 3

2017 Q2

Interim Disclosures on Regulatory Capital

 

– 

Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Interim Disclosures on Leverage Ratio

 

Interim Disclosures on Pillar 3

2017 Q1

First Quarter Disclosures on Pillar 3

 

2016 Annual

 

Annual Disclosures on Regulatory Capital

 

– 

Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Annual Disclosures on Leverage Ratio

2016 Interim

Interim Disclosures on Regulatory Capital

 

– 

Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Interim Disclosures on Leverage Ratio

 

2015 Annual

 

Annual Disclosures on Regulatory Capital

 

– 

Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

Annual Disclosures on Leverage Ratio

2015 Interim

 

Interim Disclosures on Regulatory Capital

 

– 

Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

 

Interim Disclosures on Leverage Ratio

 

2014 Annual

Annual Disclosures on Regulatory Capital

 

– 

Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2014 Interim

Interim Disclosures on Regulatory Capital

 

– 

Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

 

2013 Annual

Annual Disclosures on Regulatory Capital

 

– 

Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)

2013 Interim

Interim Disclosures on Regulatory Capital

 

– 

Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)